Format
Items per page
Sort by

Send to:

Choose Destination

Results: 8

Cited In for PubMed (Select 17452978)

1.

Gastrointestinal stromal tumor - an evolving concept.

Tornillo L.

Front Med (Lausanne). 2014 Nov 11;1:43. doi: 10.3389/fmed.2014.00043. eCollection 2014. Review.

2.

Recent advances in the treatment of gastrointestinal stromal tumors.

Serrano C, George S.

Ther Adv Med Oncol. 2014 May;6(3):115-27. doi: 10.1177/1758834014522491. Review.

3.

Gastrointestinal stromal tumor and its targeted therapeutics.

Dupart J, Zhang W, Trent JC.

Chin J Cancer. 2011 May;30(5):303-14. Review.

4.

Inhibition of KIT RNAi mediated with adenovirus in gastrointestinal stromal tumor xenograft.

Wang TB, Huang WS, Lin WH, Shi HP, Dong WG.

World J Gastroenterol. 2010 Oct 28;16(40):5122-9.

5.

Imatinib upregulates compensatory integrin signaling in a mouse model of gastrointestinal stromal tumor and is more effective when combined with dasatinib.

Rossi F, Yozgat Y, de Stanchina E, Veach D, Clarkson B, Manova K, Giancotti FG, Antonescu CR, Besmer P.

Mol Cancer Res. 2010 Sep;8(9):1271-83. doi: 10.1158/1541-7786.MCR-10-0065. Epub 2010 Aug 24.

6.

A G-rich sequence within the c-kit oncogene promoter forms a parallel G-quadruplex having asymmetric G-tetrad dynamics.

Hsu ST, Varnai P, Bugaut A, Reszka AP, Neidle S, Balasubramanian S.

J Am Chem Soc. 2009 Sep 23;131(37):13399-409. doi: 10.1021/ja904007p.

7.

Targeting human gastrointestinal stromal tumor cells with a quadruplex-binding small molecule.

Gunaratnam M, Swank S, Haider SM, Galesa K, Reszka AP, Beltran M, Cuenca F, Fletcher JA, Neidle S.

J Med Chem. 2009 Jun 25;52(12):3774-83. doi: 10.1021/jm900424a.

8.

Protein kinase C-theta regulates KIT expression and proliferation in gastrointestinal stromal tumors.

Ou WB, Zhu MJ, Demetri GD, Fletcher CD, Fletcher JA.

Oncogene. 2008 Sep 18;27(42):5624-34. doi: 10.1038/onc.2008.177. Epub 2008 Jun 2.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk